medigraphic.com
ISSN 1028-4796 (Print)

2012, Number 3

<< Back Next >>

Rev Cubana Plant Med 2012; 17 (3)

Effect of Morinda citrifolia L. (noni) in analgesic models

Sánchez RN, Bu WM, Pérez-Saad H, Lara FG, Scull I

Language: Spanish
References: 35
Page:
PDF size: 137.47 Kb.


ABSTRACT

Introduction: Morinda citrifolia L. (noni) has aroused great interest and expectations in the Cuban population due to attributed medicinal properties. Several research works have suggested the analgesic effect of several parts of the plant.
Objectives: to evaluate the effect of Noni juice in different analgesic models.
Methods: there were used 450, 900, and 1 800 mg/kg doses of the juice, based on the dry content weight. They were administered intraperitonealy to adult male mice OF1 in the peritoneal irritation model induced by acetic acid at 0.6 % concentration, and the number of contorsions or stretchings was quantified. Additionally, the hot plate and the tail immersed in hot water models were applied.
Results: the noni juice was effective in reducing the number of contortions induced by the acetic acid in a dose-dependent manner. Just the highest dose of the juice increased significantly the time of reaction in the hot plate and in the tail immersion test.
Conclusions: these results suggest that the analgesic effect of Noni juice is basically peripheral.


REFERENCES

  1. Basar S, Uhlenhut K, Högger P, Schöne F, Westendorf J. Analgesic and antiinflammatory activity of Morinda citrifolia L. (Noni). Fruit Phytother Res. 2010;24:38-42.

  2. Dixon AR, McMillan H, Atkin NL. Ferment this: The transformation of Noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Econ Bot. 1999;53:51-68.

  3. McClatchey W. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integr Cancer Ther. 2002;1:110-20.

  4. Pande M, Naiker N, Mills G. The Kura files: qualitatively social survey. Pacific Health Surv Resp. 2005;12:85-93.

  5. Chan-Blanco Y, Vaillant F, Perez AM, Reynes M, Brillouet J-, Brat Pierre. The noni fruit (Morinda citrifolia L.): A review of agricultural research, nutritional and therapeutic properties. J Food Composition Analysis. 2006;19:645-54.

  6. Pawlus AD, Kingshorn DA. Review of the ethnobotany, chemistry,biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J Pharm Pharmacol. 2007;59:1587-609.

  7. Yang J, Gadi R, Paulino R, Thomson T. Total phenolics, ascorbic acid, and antioxidant capacity of noni (Morinda citrifolia L.) juice and powder as affected by illumination during storage. Food Chemistry. 2010;122:627-32.

  8. Yang J, Paulino R, Janke-Stedronsky S, Abawi F. Free-radical-scavenging activity and total phenols of noni (Morinda citrifolia L.) juice and powder in processing and storage. Food Chemistry. 2007;102:302-8.

  9. Heinicke R Phd. The Pharmacologically active ingredients of Noni. Pacific Trop Bot Garden Bull Univ Hawaii. 1985;5(1).

  10. Solomon N. The Noni phenomenon. Discover the powerful tropical healer that fights cancer, lowers high blood pressure and relieves chronic pain. Vineyard, Utah: Direct Source Publishing; 1999. p. 296.

  11. Potterat O, Hamburger M. Morinda citrifolia (Noni) fruit-phytochemitry pharmacology safety. Planta Med. 2007;73:191-9.

  12. Commission E. Commission decision of 5 June 2003 authorizing the placing on the market of `noni juice' (juice of the fruit of Morinda citrifolia L.) as a novel food ingredient under regulation (EC) No 258/97 of the European parliament and of the council. Europe: Official Journal of the European Union; 2003. p. 12.

  13. West BJ, Jensen CJ, Westendorf J. A safety review of noni fruit juice. J Food Sci. 2006;71:R100-R6.

  14. Westendorf J, Effenberger K, Iznaguen H. Toxicological and analytical investigations of noni (Morinda citrifolia) fruit juice. J Agric Food Chem. 2007;55:529-37.

  15. Younos C, Rolland A, Fleurentin J, Lanhers MC, Misslin R, Mortier F. Analgesic and behavioral effects of Morinda citrifolia. Planta Med. 1990;56:430-4.

  16. Turner RA, editor. Screening methods in pharmacology. New York: Academic Press; 1965. p. 100-17.

  17. Lapa AJ, Monteiro de Lima TC. Métodos farmacológicos para el estudio de la actividad analgésica/antiinflamatoria. En: Lapa AJ, Souccar C, Lima-Landman MTR, Monteiro de Lima TC, editores. Métodos de Evaluación de la Actividad Farmacológica de Plantas Medicinales. Sao Paulo: CYTED/CNPq; 2002. p. 60-71.

  18. Gupta MP, editor. 270 Plantas Medicinales Iberoamericanas. Santa Fe de Bogotá: CYTED-SECAB; 1995. p. 99-324.

  19. Bu M, Sánchez N, Pérez-Saad H, Lara G, Scull I. Efecto neurofarmacológico del zumo de Morinda citrifolia. BLACPMA. 2011;10:2.

  20. Roger N. Acciones selectivas de los barbitúricos sobre la transmisión sináptica. En: Lipton MA, DiMascio A, Killan KF, editores. Psicofarmacología. La Habana: Editorial Científico-Técnica; 1982. p. 1491-503.

  21. De Vry JM, Denzer D, Reissmueller E, Eijckenboom M, Heil M, Meier H,Mauler F.3- [2- Cyano- 3- (trifluoromethyl) phenoxy] phenyl -4, 4 ,4-trifluoro-butanesulfonate (BAY 59-3074): a novel Cannabinoid CB1/CB2 receptor partial agonist with antihyperalgesic and anti-allodynic effects. J Pharmacol Exp Ther. 2004:12.

  22. Whittle BA. The use of changes in capillary permeability in mice to distinguish between narcotic and non narcotic analgesics. Br J Pharmacol. 1964;22:246-53.

  23. Von Voigtlander PF, Lewis RA. Air-induced writhing: a rapid broad spectrum assay for analgesics. Drug Dev Res. 1982;2:577-81.

  24. Vogel HG, Vogel WH. Writhing tests. Drug discovery and evaluations. Pharmacological assays. 2nd ed. New York: Springer-Verlag Berlin; 2002. p. 759-867.

  25. Tjolsen A, Rosland JH, Berge OG, Hole K. The increasing temperature hot plate test: an improved test of nocioception in mice and rats. J Pharmacol Methods. 1991;25:241-50.

  26. Llanio M, Pérez-Saad H, Garriga E. Tolerancia inducida por una dosis única de morfina. Las neurociencias en la salud del hombre. La Habana: Editorial Academia; 1990. p. 100-3.

  27. Cryns K, van Alphen AM, van Spaendonck MP, van de Heyning PH, Timmermans JP, de Zeeuw CI, et al. Circling behavior in the Ecl mouse is caused by lateral semicircular canal defects. J Comp Neurol. 2004;468:587.

  28. Betz J. Polynesia `s natural pharmacy. United Kingdom: Ed. Pride Publishing; 1997: p 13.

  29. Wang MY, West B, Jensen CJ, Nowicki D, Su C, Palu AK, Anderson, G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sinica. 2002;23:1127-41.

  30. Punjanon T, Nandhasri P. Analgesic effects of the alcoholic extract from fruits of Morinda citrifolia. Acta Hort. 2005;(ISHS):103-6.

  31. Heinicke R. The Xeronine system: a new cellular mechanism that explains the health promoting action of Noni and Bromelian. Canada: Direct Source Publishing W.J.S. Inc.; 2001.

  32. Peter PI. Noni. Cli Res J. 2007:1(1-2):44.

  33. Migraña y Noni parte II [serie en Internet]. [citado 3 Oct 2011]. Disponible en: http://www.salud.com/salud-en-general/la-migrana-y-el-noni-parte-ii.asp

  34. Heinicke R. Noni juice, xeronine, damnacanthal & scientific studies [serie en Internet]. [citado 17 Jun 2003]. Noni juice from Maui, Hawaii. Disponible en: http://www.nonimaui.com/noni_.news heinicke.html

  35. Kilham C. Noni (Morinda citrifolia). Fruit and its uses [serie en Internet]. [citado 14 may 2003]. Disponible en: http://www.naturalinvestot.com/manzone/2_01/supplier /noni.cfm?path=ex




2020     |     www.medigraphic.com